Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for parotid tumors, neoplasms arising in the parotid gland, is witnessing a gradual increase in incidence globally. Due to technological progresses in imaging modalities, such as ultrasound, MRI and CT scans, the diagnosis and definition of these neoplasms have now been simplified beyond comprehension. With these imaging tools, healthcare providers are able to diagnose tumors accurately on the basis of key parameters such as tumor size, location, and morphology and thereby help take informed decisions regarding treatment in the hope of achieving better patient outcomes.
Parotid tumors comprise of a many histological varieties starting from benign to malignant tumors, such as squamous cell carcinoma (SCC) or parotid duct carcinoma, with varying behavior and therapies. Accurate histological differentiating distinguishes among types of cancers through biopsy and pathological investigations that determine appropriate treatment option and affords patients understanding of their own outcomes.
Surgery is still primarily used as a treatment for parotid gland tumors, in combination with the total removal of tumors while preserving the intact function of the facial nerve and maintaining esthetics. Surgical undertakings, such as, the nerve monitoring, facial nerve mapping and minimum intervention, are leading to a greater number of successful operations and comparatively lower complication rates.
Among the adjuvant therapies, the irradiation therapy and chemotherapy have a very vital role in the control of malignant parotid tumor to ensure the elimination of residual disease that usually results to recurrence. Radiation as an adjoinctive technique to surgery may be used in Grade III tumors while chemotherapy is mostly suitable for cancerous tumors that have spread to other organs.
Through the discovery of molecularly targeted drugs, as well as immunotherapies and targeted therapy, there is a strong indication that advanced and treatment-resistant parotid tumors might be treated. This type of pharmaceuticals goal is exactly to stop those molecular ways involved with cancer cell growth and development, presenting personalized therapies with probably fewer side effects than common chemotherapy.
Precise and targeted therapy for parotid tumors has been getting more attention thanks to the new molecular profiling and genetic testing. Particularly, mutation identification is a crucial issue allowing people to choose the right treatment. Molecular diagnosis provides an identification of the molecules, or parts, of a tumor, which makes it possible to categorize patients according to their tumor's molecular characteristics. This, in turn, opens up the option of dedicated personalized treatment for patients with high chances of treatment outcome.
A joint effort is required to handle parotid tumors that includes the participation of all members of the multidisciplinary team consisting of the otolaryngologists, head and neck surgeons, medical and radiation oncologists, pathologists and radiologists. Multidisciplinary tumor boards are heading to the holistic treatment planning that comprises various treatments; for instance, surgery, medicines, excessive exposure to radiation beams; and they are all customized for each patient.
Ongoing research and clinical trials focus on exploring novel therapeutic approaches, biomarkers, and treatment strategies in the parotid tumor market. Collaborative efforts between academic institutions, industry partners, and regulatory agencies drive innovation and shape the development of next-generation therapies for parotid tumors.
Parotid Tumors Market Highlights:
Global Parotid Tumors Market Overview
Parotid Tumors Market Size was valued at USD 3.27 Billion in 2023. The Global Parotid Tumors industry is projected to grow from USD 3.35 Billion in 2024 to USD 7.82 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.46% during the forecast period (2024 - 2032).
Parotid Tumors are abnormal growth within the salivary gland. The parotid glands are prone to various conditions like fibrous reaction, parotitis, salivary stones, injury, cancers, and parotid tumors. The parotid tumor can be cancerous or non-cancerous.
Parotid Tumors can be caused by various reasons such as certain abdominal surgery, liver cirrhosis, dehydration, salivary gland infections, metastasis of cancer, and salivary duct stones.
The parotid tumors market is majorly driven by growing prevalence of cancer, growing liver cirrhosis, and rising consumption of alcohol. Additionally, factors such as government initiatives and support, rising demand for advanced technologies and growing market players offering newer products are likely to drive the market.
According to Cancer Research U.K, around 14.1 million cases of cancer were diagnosed in 2014. Additionally, according to national cancer institute in 2014, around 14.5 million cases of cancer went undiagnosed. Such statistics has propelled the overall number of cancer cases and thereby are likely to drive the growth of parotid tumors market.
Factors that are likely to hamper the growth of the market are the complications that will arise after the needed treatment.
Intended Audience
- Pharmaceutical Manufacturers and Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Parotid Tumors Market Segmentation
The parotid tumors market is segmented on the basis of type, treatment, diagnosis and end users.
By the type Pleomorphic Adenoma, Warthin's Tumor and Cancerous/Malignant Tumor.
On the basis of treatment, the parotid tumors market is segmented into Parotidectomy, Removal of Lymph Node, Reconstructive Surgery, Radiation Therapy, and Chemotherapy.
By diagnosis, the parotid tumors market is segmented into X-ray, CT scan, MRI, Ultrasound, FNAC (Fine Needle Aspiration Cytology), Sialography, and others.
On the basis of the end users, the parotid tumors market is segmented into hospitals, Specialty centers, and Research centers.
Parotid Tumors Market Regional Analysis
North America Parotid Tumors market is a growing market in the Americas region. On a regional basis, Americas region is segmented into North America and South America. North America is segmented into US and Canada. Increasing number of cancer and rising consumption of alcohol among the masses is likely to drive the growth of North America Parotid Tumors market. Additionally, rising healthcare expenditure is likely to drive the growth of the market. For instance, according to National Institute on alcohol abuse and alcoholism, in 2015, around 26.9% individuals aged 18 and above are engaged in drinking.Similarly, according to Agency for Healthcare Research and Quality (AHRQ), around USD 80.2 billion was spent in cancer treatment.
Europe is the second largest market and holds a noticeable share in the Parotid Tumors market. The European market is expected to grow a healthy growth during the forecast period owing to the availability of newer and advanced treatment facilities, and rising skilled medical professionals along with growing need for better healthcare infrastructure. Furthermore, extensive research and development activities for the treatment of disease and increasing government support and initiative boost the parotid tumors market growth.
Asia Pacific is expected to be the fastest growing market. Increasing prevalence of chronic diseases is the major driver for the market growth. India is the fastest growing region owing to an increasing population. Rising awareness about the health and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drive the parotid tumors market.
The Middle East & Africa is expected to show the least growth in the parotid tumors market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, United Arab Emirates is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.
Parotid Tumors Market Key Players
Some of the players in the Parotid Tumors market are:
- Eli Lilly & Co
- Bayer AG
- Merck & Co. Inc.
- Pfizer Inc.
- Bristol-Myers Squibb
- Janssen Global Services, LLC
- Hoffmann-La Roche Ltd
- Novartis AG
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
